Skip to main content

News

By Henry Powderly | 11:43 am | September 24, 2015
Nonprofits had held back on issuing bonds when the Affordable Care Act took effect on 2013 over concerns that disruptions in cash flow tied to reforms would make it harder to pay back debt for capital improvements.
By Kaiser Health News | 10:02 am | September 24, 2015
The health law's upcoming enrollment period may be its toughest yet, with federal officials promising a vigorous outreach campaign to enroll millions of eligible yet hard-to-reach Americans who have yet to sign up for health insurance.
By Susan Morse | 09:01 am | September 24, 2015
Mark T. Bertolini, chairman and CEO of Aetna in Hartford, Connecticut and Joseph R. Swedish, president and CEO of Anthem in Indianapolis, argued before a Senate Judiciary subcommittee on Antitrust, Competition Policy and Consumer Rights on Tuesday that local insurance plans would keep the industry competitive.
By Susan Morse | 11:29 am | September 23, 2015
Shkreli was blasted for increasing the cost of a drug considered life-saving for those with weakened immune systems, such as AIDS patients and those with cancer.
By Kaiser Health News | 10:48 am | September 23, 2015
Dedicated funding is needed for research, the report says, and hospitals and doctors need to develop better ways to identify, reduce and learn from "near misses."
By Kaiser Health News | 10:17 am | September 23, 2015
Forty-six percent of covered workers have a deductible of at least $1,000 this year for single coverage as employers shift to "consumer-directed" plans that give members incentives to seek less-costly care.
By Healthcare Finance Staff | 06:21 pm | September 22, 2015
Earlier this week, Turing Pharmaceutical CEO Martin Shkreli drew sharp criticism after his privately held company boosted the price of AIDS treatment drug Daraprim from a reported $13.50 a tablet to $750.
By Susan Morse | 06:02 pm | September 22, 2015
Earlier this week, Turing Pharmaceutical CEO Martin Shkreli drew sharp criticism after his privately held company boosted the price of AIDS treatment drug Daraprim from a reported $13.50 a tablet to $750.
By Healthcare Finance Staff | 02:38 pm | September 22, 2015
A new consumer website unveiled by the California Department of Insurance hopes to help Californians better shop for healthcare based on both quality and price.
By Healthcare Finance Staff | 02:25 pm | September 22, 2015
According to new data released by the Centers for Medicare and Medicaid Services on Monday, the U.S. government has paid nearly $2.3 billion through July in incentives to close the coverage gap in 2015.